Bridging the Gap to Access:
Patient-Centered Care in Evolving Healthcare Systems

October 21-22, 2024

MaRS Discovery District (Toronto) 101 College Street
Registration & Breakfast – Concourse Level Auditorium 7:00am
Opening remarks at 8:30am

Program

Recordings

• Day 1 
• Day 2

Slides (click on the titles)

Day 1 – October 21, 2024

Keynote: Closing The Gap by Understanding The Burden of Rare Diseases

What’s up with TAT (Turn-Around-Time)? Tackling Cancer Genomic Testing Inequities in Ontario

A Wave of Innovative Rare Disease Drugs is Coming – Is Canada’s Healthcare System Ready?

Filling the gap: The case for a policy observatory to serve the Canadian rare disease policy ecosystem

An RWE case study in oncology: Generating timely and meaningful Canadian real-world evidence to support an outcomes-based market access agreement

Are healthcare systems ready for advanced therapeutics?

Student Oral Presentation #1 – A Systematic Review and Meta-Analysis of Interventions Aimed at Delabeling Low-Risk Penicillin Allergies with Consideration for Sex and Gender

Student Oral Presentation #2 – How much does it cost the healthcare system to manage a person presenting with musculoskeletal disorder to the emergency department?

Student Oral Presentation #3 – Preparing Electronic Medical Record Data for Pharmaco-epidemiologic Research: Essential Data Validation

Student Oral Presentation #4 – Developing a drug shortages predictive model using real-world Canadian drug utilization

Day 2 – October 22, 2024

Maximizing the Impact of Patient Registries in Rare Disease

Collaborative Approaches for Incorporating Societal Value in Canadian HTA

Beyond the Diagnosis: Rethinking Type 1 Diabetes Care

Closing the Last Mile: How Improving System Readiness is Key to Faster Patient Access

Abstract Booklet

Published Abstracts

• Canadian Journal of Health Technologies, Vol. 4 Issue 12, December 2024

Awards:
Dr. E. Keith Borden Award for Students

• Best Oral Presentation – Araniy Santhireswaran, “Developing a drug shortages predictive model using real-world Canadian drug utilization”
• Best Poster Presentation – Lynn D’Souza, “CADTH’s implementation of GRADE in reimbursement reviews: a narrative review”

Peggy Kee Award – Sha Kang, “Realization of biosimilar savings in Canada: case study of ranibizumab”

Kris Schindel Award – Peggy Kee

Code of Conduct:
all attendees at the conference will be required to adhere to the CAPT Code of Conduct

 

Special thank you to our 2024 PARTNERS

Platinum
Alexion
AstraZeneca
Bayer
IQVIA
I2U
Pfizer
Roche
Sanofi
Takeda

Silver
Amgen
Cencora Innomar Strategies
Eisai
Eversana
Novartis
PDCI Market Access

Bronze
CDA-AMC
HOPE Research Centre
J.L. Glennie Consulting Inc.
PeriPharm

Ruby
Exactis